Prism Adaptation Therapy for Stroke-Related Perceptual Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new treatment called Prism Adaptation Therapy to assist individuals with spatial awareness difficulties following a stroke on the right side of the brain. Researchers aim to determine if this therapy can improve symptoms for those with spatial neglect, which involves difficulty noticing things on one side. They also seek to identify if specific brain damage patterns predict who benefits most from the therapy. Individuals who have experienced a right hemisphere stroke within the last month and struggle with spatial awareness might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance recovery options for stroke patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
What prior data suggests that Prism Adaptation Therapy is safe for stroke-related perceptual disorders?
Research shows that Prism Adaptation Therapy (PAT) has been safely used in studies with both healthy individuals and stroke patients. No safety concerns have been reported. As a non-invasive treatment, PAT does not involve surgery or entering the body, making it generally easy to tolerate. Overall, current studies suggest that PAT is a safe option for those considering clinical trials for perceptual disorders after a stroke.12345
Why are researchers excited about this trial?
Prism Adaptation Therapy is unique because it offers a non-invasive approach to address stroke-related perceptual disorders. Unlike conventional therapies that might rely on medications or extensive rehabilitation exercises, this therapy involves wearing special glasses that shift the visual field, helping the brain recalibrate and improve perception. Researchers are excited because it targets neuroplasticity, the brain's ability to reorganize itself, which could lead to faster and potentially more effective recovery in just a few sessions.
What evidence suggests that Prism Adaptation Therapy is effective for stroke-related perceptual disorders?
Prism Adaptation Therapy (PAT), which participants in this trial will receive, has been shown to help people with spatial neglect, a condition where they may not notice things on one side of their vision. Research shows that patients with spatial neglect who undergo this therapy often find it easier to perform daily tasks and think more clearly. A review of several studies found that PAT positively affects spatial awareness for those recovering from a stroke. This treatment appears promising for helping individuals regain better control and awareness of their surroundings.678910
Are You a Good Fit for This Trial?
This trial is for adults aged 18-90 who've had a right hemisphere stroke within the last month and are suspected of having spatial neglect. They must be able to consent, sit for an hour, point straight ahead, hold a pen with their right hand, and undergo MRI scans. They should not have other conditions affecting testing or training ability.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pretesting
Pretesting for type of neglect and its severity, followed by MRI with Diffusion Tensor Imaging (DTI)
Treatment
Participants complete 10 sessions of Prism Adaptation Therapy
Post-testing
Neglect post-testing to assess response to Prism Adaptation Therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Prism Adaptation Therapy
Prism Adaptation Therapy is already approved in United States for the following indications:
- Spatial neglect following right brain stroke
- Rehabilitation for stroke survivors with spatial neglect
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor